Bin Huang

Dr. Huang is an executive leader with over 30 years of experience in life sciences.  Her career began with Allelix Crop Technologies, where she spent six years as a plant research scientist. For a number of years, Dr. Huang was the President and CEO of Cytovax Biotechnologies, a Canadian biotechnology company. Following that, she led WEX Pharmaceuticals, a subsidiary of publicly listed CK Life Sciences International (Holdings) Inc., as President and CEO.  Dr. Huang has a PhD in Plant Cell Biology from the University of East Anglia, UK and an MBA from the University of Toronto.

We are thrilled to welcome Bin Huang to #CannabisCon’s Cannabis Canada Forums Business Opportunity Day Friday April 13th at the Edmonton Shaw Conference Centre to join a panel discussion on Cannabis 101: General overview of cannabis: plants, effects, and consumption means, THC, CBD, strains, current medical access system (followed by Q & A with audience). Huang will also be joining the Presidents Panel: Panel discussion with senior industry executives during our Chamber of Commerce Luncheon.
We are excited to also have Huang join us for #CannabisCon’s Consumer Day on Saturday, April 14th as key speaker for Cannabis 101: General overview of cannabis: plants, effects, and consumption means, THC, CBD, strains, current medical access system (followed by Q & A with audience) and to join a panel discussion on Women in Cannabis.